DAY 1, THURSDAY, 13 FEBRUARY 2020 · 11 13:40 - 14:30 13:40 - 14:10 Bayer Sympusium: CAD patients...

4
DAY 1, THURSDAY, 13 FEBRUARY 2020 07:30 - 09:00 Registration & Welcome Coffee 1 09:00 - 10:30 09:00 - 09:05 09:05 - 09:15 09:15 - 09:25 09:25 - 09:40 09:40 - 09:50 Latest on Management of LAA Thorsten Hanke, Germany 09:50 - 10:00 10:00 - 10:10 Current Status of Paclitaxel Technology for Treatment of Femoro-Popliteal Arterial Disease Zvonimir Krajcer, USA Omar Hallak, Zvonimir Krajcer Mazen Al Sawaf, UAE Yahya Kiwan,UAE Omar Hallak, UAE Joachim Weil, Germany 10:10 - 10:20 10:20 - 10:30 Alternative Access options for TAVR, combined Cardiology & vascular Team Angela Echeverria, USA Discussion 10:30 - 11:05 Opening Ceremony 10:30 - 10:35 Holy Quran - Welcome from 4TS Chairman 10:35 - 10:40 Omar Hallak, UAE Guest of Honor: 10:40 - 10:45 H.E Humaid Al Qutami, Director General, DHA Welcome from 4TS Co-Director 10:45 - 10:50 Zvonimir Krajcer, USA Welcome from Emirates Cardiac Society President 10:50 - 10:55 Abdulmajeed Al Zubaidi, UAE Welcome from ISEVS President 10:55 - 11:00 Marvin Woodall, USA 4TS 2019 Introduction Video 11:00 - 11:05 - 11:05 - 11:30 Morning Tea & Networking Break 2 11:30 - 12:30 Hemodynamic Support Devices In Cath Lab During High Risk PCI Fayaz Shawal, USA 11:30 - 11:40 11:40 - 11:50 LM dissection with retrograde extension during PCI of LAD CTO: What is next? Debabrata Dash, UAE 11:50 - 12:00 Atherectomy for complex coronary lesions, what’s new? Faisal Hasan, UAE 12:00 - 12:10 12:10 - 12:20 12:20 - 12:30 Rotablation through guideliner following failure of bur pass previously Albert Alahmar, UAE 3 12:30 - 13:20 12:30 - 13:00 Importance of Management of Non-HDL Cholesterol for Better Cardiovascular Risk Management Alberto Zambon, Italy 13:00 - 13:10 Should combination therapy be the first line treatment? Houssein Mustafa, UAE 13:10 - 13:20 Diabets medication to deacrease Cardiac Mortality Donattela Casigilia, UAE Dr. Edward B. Diethrich Session: Latest Clinical Trials in Cardiovascular advances and trials Panelists: Omar Hallak | Zvonimir Kracjer | Christian Schumacher | Arif Nooryani | Abdulla Shehab Angela Echeverria | Mazen Al Sawaf Complex Coronary Cases Panelists: Arif Nooryani | Omar Hallak | Basel Zakman | Yahya Kiwan | Rafiq Abusamra | Fekry Eldeeb | Mehmood Butt | Praveen Chandra Dyslipidaemia Management : what is the latest? Session -I Panelists: Annie Varughese | Donatella Casigilia | Alberto Zambon | Abdul Bahro | Allam Kowatly | Houssein Mustafa | Abdul Naser Oudah Welcome to 4TS Healthcare Challenges in the Gulf Stem Cell Treatment in Cardiovascular Diseases Latest Clinical Trials in Cardiovascular Medicine Renal Denervation – Ready to go? Challenging Cardiac Case Robotic coronary bypass grafting surgery “MIDCAB" Kenneth K. Liao,USA Arif Nooryani, UAE 13:20 - 14:00 Lunch Break 4 14:00 - 15:00 Latest on PCSK9 inhibitors intermediate term data 14:00 - 14:10 Mohamed Salah, UAE 14:10 - 14:20 Reversing CVD and Diabetes Annie Varughese, USA Dyslipidaemia Management : what is the latest? - Session -II Panelists: Nooshin Bagarzani | Alberto Zambon | Annie Varugese | Allam Kowatly | Mohamed Salah | Amer Dardary| Laila Al Marsoqui 4TS CONFERENCE 2020

Transcript of DAY 1, THURSDAY, 13 FEBRUARY 2020 · 11 13:40 - 14:30 13:40 - 14:10 Bayer Sympusium: CAD patients...

Page 1: DAY 1, THURSDAY, 13 FEBRUARY 2020 · 11 13:40 - 14:30 13:40 - 14:10 Bayer Sympusium: CAD patients in focus, Who stands to benefit from Rivaroxaban vascular dose plus ASA Management

DAY 1, THURSDAY, 13 FEBRUARY 2020

07:30 - 09:00 Registration & Welcome Coffee

1 09:00 - 10:30

09:00 - 09:05

09:05 - 09:15

09:15 - 09:25

09:25 - 09:40

09:40 - 09:50

Latest on Management of LAA Thorsten Hanke, Germany09:50 - 10:00

10:00 - 10:10Current Status of Paclitaxel Technology for Treatment of Femoro-Popliteal Arterial Disease

Zvonimir Krajcer, USA

Omar Hallak, Zvonimir Krajcer

Mazen Al Sawaf, UAE

Yahya Kiwan,UAE

Omar Hallak, UAE

Joachim Weil, Germany

10:10 - 10:20

10:20 - 10:30

Alternative Access options for TAVR, combined Cardiology & vascular Team Angela Echeverria, USA

Discussion

10:30 - 11:05 Opening Ceremony

10:30 - 10:35 Holy Quran -

Welcome from 4TS Chairman10:35 - 10:40 Omar Hallak, UAE

Guest of Honor: 10:40 - 10:45 H.E Humaid Al Qutami,Director General, DHA

Welcome from 4TS Co-Director10:45 - 10:50 Zvonimir Krajcer, USA

Welcome from Emirates Cardiac Society President10:50 - 10:55 Abdulmajeed Al Zubaidi, UAE

Welcome from ISEVS President10:55 - 11:00 Marvin Woodall, USA

4TS 2019 Introduction Video11:00 - 11:05 -

11:05 - 11:30 Morning Tea & Networking Break

2 11:30 - 12:30

Hemodynamic Support Devices In Cath Lab During High Risk PCI Fayaz Shawal, USA11:30 - 11:40

11:40 - 11:50 LM dissection with retrograde extension during PCI of LAD CTO: What is next? Debabrata Dash, UAE

11:50 - 12:00 Atherectomy for complex coronary lesions, what’s new? Faisal Hasan, UAE

12:00 - 12:10

12:10 - 12:20

12:20 - 12:30

Rotablation through guideliner following failure of bur pass previously Albert Alahmar, UAE

3 12:30 - 13:20

12:30 - 13:00 Importance of Management of Non-HDL Cholesterol for Better CardiovascularRisk Management

Alberto Zambon, Italy

13:00 - 13:10 Should combination therapy be the first line treatment? Houssein Mustafa, UAE

13:10 - 13:20 Diabets medication to deacrease Cardiac Mortality Donattela Casigilia, UAE

Dr. Edward B. Diethrich Session:Latest Clinical Trials in Cardiovascular advances and trialsPanelists: Omar Hallak | Zvonimir Kracjer | Christian Schumacher | Arif Nooryani | Abdulla Shehab

Angela Echeverria | Mazen Al Sawaf

Complex Coronary CasesPanelists: Arif Nooryani | Omar Hallak | Basel Zakman | Yahya Kiwan | Rafiq Abusamra | Fekry Eldeeb |

Mehmood Butt | Praveen Chandra

Dyslipidaemia Management : what is the latest? Session -IPanelists: Annie Varughese | Donatella Casigilia | Alberto Zambon | Abdul Bahro | Allam Kowatly |

Houssein Mustafa | Abdul Naser Oudah

Welcome to 4TS

Healthcare Challenges in the Gulf

Stem Cell Treatment in Cardiovascular Diseases

Latest Clinical Trials in Cardiovascular Medicine

Renal Denervation – Ready to go?

Challenging Cardiac Case

Robotic coronary bypass grafting surgery “MIDCAB" Kenneth K. Liao,USA

Arif Nooryani, UAE

13:20 - 14:00 Lunch Break

4 14:00 - 15:00

Latest on PCSK9 inhibitors intermediate term data 14:00 - 14:10 Mohamed Salah, UAE

14:10 - 14:20 Reversing CVD and Diabetes Annie Varughese, USA

Dyslipidaemia Management : what is the latest? - Session -IIPanelists: Nooshin Bagarzani | Alberto Zambon | Annie Varugese | Allam Kowatly | Mohamed Salah |

Amer Dardary| Laila Al Marsoqui

4TS CONFERENCE 2020

Page 2: DAY 1, THURSDAY, 13 FEBRUARY 2020 · 11 13:40 - 14:30 13:40 - 14:10 Bayer Sympusium: CAD patients in focus, Who stands to benefit from Rivaroxaban vascular dose plus ASA Management

14:20 - 14:50 Pfizer Symposium: Impacting Patient Live with NCD Khalid Malik, UAE

14:50 - 15:00 Discussion

5 15:00 - 15:40

15:00 - 15:10 Complex Vascular Case N N Khanna, India

15:10 - 15:20 Complex Vascular case Manar Trab, UAE

Complex vascular Case

Coaroctation of the aorta Waleed Kadro, UAE

15:20 - 15:30 N N Khanna, India

15:30 - 15:40

15:40 - 16:00 Evening Tea & Networking Break

6

7

16:00 - 16:40

16:00 - 16:10 Direct Access Mitral Valve-in-Valve Replacement in Complex Third Time Reoperation on a High Risk Patient Ahmed El-Eshmawi, USA

16:10 - 16:20Presentation Use of TAVR in Low Flow Low Gradient critical Aortic Stenosis :Which patients will benefit?

Fayaz Shawl, USA

16:20 - 16:30 Latest data on Transcatheter Mitral Valve in Valve Replacement

Mitral Valve Intervention Praveen Chandra, India

Carl Kapadia, USA

16:30 - 16:40

16:40 - 17:30

16:40 - 16:50 Long term surveillance of cyanoacrylate obliteration of veins: what is the real mechanism of actions? Francesco Serino, UAE

16:50 - 17:00

17:00 - 17:10

17:10 - 17:20Erectile dysfunction by cavernovenous leak resistant to medical treatment: novel approach with hemodynamic assessment, embolization, open surgery

Eric Allaire, France

17:20 - 17:30 Discussion

SVC syndrome Case

Chronic venous insufficiency management Mohammad Sobeh, UAE

Amira Benjelloun, Morocco

APVS Session: Arterial casesPanelists: N N Khanna | Faisal Hassan | Carl Kapadia | Francesco Serino | Mohamad Sobeh | Eric Allaire

Structural Heart Disease InterventionPanelists: Praveen Chandra | Ahmed El-Eshmawi | Kenneth K. Liao | Thorsten Hanke | Mohamad Salem

Hussain Mustafa

ISEVS Session: Venous interventionPanelists: Ayman Kamel | Amit Kumar | Amira Benjelloun | Zvonimir Kracjer | Rafik Abusamra

Manar Trab | Ayman Sebaie | Jacques Busquet

DAY 2, FRIDAY, 14 FEBRUARY 2020

07:30 - 08:30 Registration & Welcome Coffee

8 08:30 - 09:30

08:30 - 08:40 What Are the Next Generation Large Sheath Closure Devices

Latest on type B dissection management Jacques Busquet, France

Zvonimir Kracjer, USA

08:40 - 08:50

08:50 - 09:00 Treatment of Aortic Dissection with new Zenith dissection Stent Graft Angela Echeverria, USA

09:00 - 09:30 Discussion

Case of 3VD

Challenging intervention Case

My nightmare in the cathlab Joachim Weil, Germany

Allam Kowatly, UAE

Mahmoud Butt,UK

09:30 - 10:30

09:30 - 09:40

09:40 - 09:50

09:50 - 10:00

ISEVS Session : Endovascular Aortic InterventionPanelists: Zvonimir Kracjer | Francesco Serino | Jacques Busquet | Amira Benjelloun | NN Khanna |

Mohammed Helaly | Angela Echeverria

Complex Coronary InterventionPanelists: Waleed Kadro | Omar Hallak | Mahmoud Butt | Albert Alahmar | Naji Yazbek |

Abdul Naser Oudah | Ahmed El-Eshmawi | Abdul Bahro

DAY 1, THURSDAY, 13 FEBRUARY 2020

9

4TS CONFERENCE 2020

Page 3: DAY 1, THURSDAY, 13 FEBRUARY 2020 · 11 13:40 - 14:30 13:40 - 14:10 Bayer Sympusium: CAD patients in focus, Who stands to benefit from Rivaroxaban vascular dose plus ASA Management

11 13:40 - 14:30

13:40 - 14:10Bayer Sympusium: CAD patients in focus, Who stands to benefit from Rivaroxaban vascular dose plus ASA

Management of Bleeding in patients on NOAC

NOAC for DVT/PE Hassan Hareri, UAE

Hassan El Tamimi, UAE

Ghazi Radaideh,UAE

14:10 - 14:20

14:20 - 14:30

14:30 - 15:00

14:30 - 15:00Amgen Symposium: Role of Evolocumab in management of Dyslipidemiawith Diabetic patients Tarek Mohammed Fiad,UAE

15:00 - 15:30 Sandoz Symposium: Dyslipidemia Management Guidelines and Updates Abdullah Shehab,UAE

15:30 - 15:50 Afternoon Coffee & Networking Break

12 15:50 - 16:50

15:50 - 16:00 Evaluation and Treatment of Iliac Vein Compression Syndrome: Who Needs it and How Should it be Done?

Update on endovascular therapy for SFA In-stent occlusion

Challenging BTK intervention case

Upper extremity ischemia

Challenging Vascular Case Walid Kadro, UAE

Abdul Bahro, USA

Mohamed Salem, UAE

Faisal Hasan, UAE

Zvonimir Krajcer , USA

16:00 - 16:10

16:10 - 16:20

16:20 - 16:30

16:30 - 16:40

New Oral Anticoagulation / AntiplatletPanelists: Abdula Shehab | Nooshin Bazargani | Rania Khani | Amrish Aggrawal | Manal Fahham |

Vittorio Iantorno | Tamkeen Kinnah

ISEVS Session: Critical Leg Ischemia CasesPanalists: Zvonimir Krajcer | NN Khanna | Jacques Busquet | Francesco Serino | Angela Echeverria |

Amira Benjilloun | Mohammed Sobeh

Dyslipidemia Symposium IIPanelists: Ghazi Radaideh | Nooshin Bazargani | Abdulla Shehab | Rania Khani | Bassam Baba |

Abdul Bahro

External illiac artery psudoanurysm cusing acute leg ischemia 16:40 - 16:50 Sidharth Rajput, Australia

DAY 2, FRIDAY, 14 FEBRUARY 2020

Antiplatlet /anticogulation in High risk CVD patients

Live in a “Box“: How to complete a Successful complex PCI Fayaz Shawl, USA

Abdullah Shehab,UAE10:00 - 10:10

10:10 - 10:40

10:40 - 10:50 Discussion

10:50 - 11:10 Morning Tea & Networking Break

10 11:10 - 12:20

11:10 - 11:20 TAVI complicated with left main occlusion rescued with bailout left main PCI

Mitral Ballon Valvuluplasty Case Fekry Eldeeb, UAE

Carl Kapadia , USA

11:20 - 11:30

11:30 - 11:40 Silent Leaflet Thrombosis After TAVR: What Are the Causes and How to treat it

Paravalvular leak cases

Neochord procedure Ahmed El-Eshmawi,USA

Kenneth K. Liao, USA

Zvonimir Krajcer , USA

11:40 - 11:50

11:50 - 12:00 Treatment of functional mitral using a right-heart transcatheter mitral valve repair device Joachim Weil, Germany

12:00 - 12:10

12:10 - 12:20 Discussion

Prayer Time & Lunch Break12:20 - 13:40

Structural Heart InterventionsPanelists: Omar Hallak | Uwi Klima | Fawzi Safadi | Joachim Weil | Obaid Jaseem | Ahmed El-Eshmawi

Abdul Bahro

4TS CONFERENCE 2020

Page 4: DAY 1, THURSDAY, 13 FEBRUARY 2020 · 11 13:40 - 14:30 13:40 - 14:10 Bayer Sympusium: CAD patients in focus, Who stands to benefit from Rivaroxaban vascular dose plus ASA Management

4TS CONFERENCE 2020

Latest guidelines on STEMI Abdula Shehab, UAE

DAY 3, SATURDAY, 15 FEBRUARY 2020

07:30 - 08:30 Registration & Welcome Coffee

08:30 - 09:5014

08:30 - 08:40

08:40 - 08:50

08:50 - 09:00

09:00 - 09:10

09:10 - 09:20

09:20 - 09:30

09:30 - 10:00

10:00 - 10:10

10:10 - 10:20

10:20 - 10:30 Discussion

Minimally Invasive Valve Surgery

When TAVR is not an option

When surgery is better for revascularization

Dubai Technique for Mitral Repair

Heart and lung transplantation Kenneth K. Liao, USA

Faouzi Safadi, UAE

Obaid Al Jasem, UAE

Heyman Lukraz, UAE

Kenneth K. Liao, USA

10:30 - 11:00 Morning Tea & Networking Break

15 11:00 - 12:00

11:00 - 11:10

11:10 - 11:20

11:20 - 11:30

11:30 - 11:40

11:40 -11:50

11:50 - 12:00 Discussion

End of Conference: Closing Statement Omar Hallak, Zvonimir Krajcer12:00 - 12:10

ACS InterventionPanelists: Abdullah Shehab | Abdulmajeed Zubaidi | Carl Kapadia | Abdul Bahro | Waleed Kadro |

Faisal Hasan | Omar Hallak | Kenneth K. Liao

Cardiac SurgeryPanelists: Obaid Jaseem | Omar Hallak | Sameer Diwale | N N Khanna | Faouzi Safadi | Fekry Eldeeb |

Waleed Kadro | Rafiq Abusamra

Early Physological guidance of PCI

STEMI and MVD

Challenging case of STIMI

When Thrombolytic is good option for STEMI

LM intervention during ACS

Managing arrythmia Post MI

Device Therpy post MI, ICD/CRT when

Anticoagulation in paitient with Afib and ACS Omar Elhaj,UAE

Hani Sabbour,UAE

Mohamed Magdy, UAE

Bassam Baba, UAE

Amrish Agrawal, UAE

Fekry Eldeeb, UAE

Abdul Majeed Zubaidi, UAE

Hussien Heshmat Kassem, UAE

DAY 2, FRIDAY, 14 FEBRUARY 2020

Latest Guideline on DVT/PE management

Intervention case of PE

Current evidence on the treatment of acute ilio-femoral DVT

Case of Dialysis Access Interventions

Case of Ischemic Hand

Potential risk during EKOS for PE Ahmed O Hallak, USA

Abdul Bahro, USA

Hussien Heshmat Kassem, UAE

Francesco Serino, UA

Hussien Heshmat Kassem,UAE

Julio Gomez-Seco, UAE

13 16:50 - 17:50

16:50 - 17:00

17:00 - 17:10

17:10 - 17:20

17:20 - 17:30

17:30 - 17:40

17:40 - 17:50

DVT/ PE/ HD Fistula InterventionPanelists: Fekry Eldeeb | Francesco Serino | Hassan Hariri | Waleed Kadro |Abdul Naser Oudah |

Mohamad Salem | Rafiq Abusamra